S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
$0.08
$0.08
$0.07
$1.25
$2.31M-0.0683,213 shs27,920 shs
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
$4.78
-0.4%
$5.53
$2.51
$6.97
$63.67M1.17119,252 shs35,906 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$18.78
+2.8%
$17.64
$14.51
$22.99
$65.92M0.68,086 shs6,217 shs
Titan Medical Inc. stock logo
TMDI
Titan Medical
$0.14
-26.3%
$0.23
$0.13
$1.20
$15.67M2.364.83 million shs7.71 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
+2.56%-10.59%-5.00%-7.32%-91.11%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
+0.84%-6.43%-18.64%+21.83%+0.52%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-1.83%+0.61%+6.16%-12.96%+14.84%
Titan Medical Inc. stock logo
TMDI
Titan Medical
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
1.6757 of 5 stars
3.50.00.04.50.61.70.0
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
0.1861 of 5 stars
0.02.00.00.01.81.70.6
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
3.00
Buy$2.503,032.83% Upside
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
$80K28.83N/AN/A($0.41) per share-0.19
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/A$3.47 per shareN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$46.09M1.43$2.28 per share8.22$8.91 per share2.11
Titan Medical Inc. stock logo
TMDI
Titan Medical
$20.09M0.78N/AN/A$0.32 per share0.44

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
-$14.14M-$0.39N/AN/AN/AN/A-142.69%N/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$23.52M-$1.92N/AN/AN/AN/A-70.17%-64.68%5/6/2024 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$7.07M$0.7525.04N/A5.59%8.97%5.40%5/2/2024 (Estimated)
Titan Medical Inc. stock logo
TMDI
Titan Medical
-$14.86M-$0.19N/AN/AN/A-167.03%-112.15%N/A

Latest TMDI, PDEX, NMRD, and NVNO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/29/2024Q4 2023
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/A-$0.32-$0.32-$0.32N/AN/A
2/12/2024Q3 2024
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
N/A-$0.12-$0.12-$0.17N/AN/A
2/8/2024Q2 2024
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/A$0.14+$0.14$0.14N/A$12.59 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
N/AN/AN/AN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
N/A
0.19
0.03
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/A
34.22
34.23
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.26
3.66
2.16
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/A
1.41
1.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
4.41%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
34.71%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Titan Medical Inc. stock logo
TMDI
Titan Medical
3.55%

Insider Ownership

CompanyInsider Ownership
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
41.60%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
17.00%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
42.60%
Titan Medical Inc. stock logo
TMDI
Titan Medical
0.02%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Nemaura Medical Inc. stock logo
NMRD
Nemaura Medical
3628.90 million16.88 millionOptionable
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
1913.32 million11.05 millionOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1453.51 million2.02 millionNot Optionable
Titan Medical Inc. stock logo
TMDI
Titan Medical
49111.95 million111.93 millionNot Optionable

TMDI, PDEX, NMRD, and NVNO Headlines

SourceHeadline
Titan Medical Inc.: Titan Medical Reports Fiscal Year 2023 ResultsTitan Medical Inc.: Titan Medical Reports Fiscal Year 2023 Results
finanznachrichten.de - April 1 at 8:49 AM
Titan Medical signs deal to merge with Conavi MedicalTitan Medical signs deal to merge with Conavi Medical
msn.com - March 21 at 4:35 AM
Titan Medical Inc TMDIFTitan Medical Inc TMDIF
morningstar.com - February 27 at 7:19 PM
Perifery appoints Titan Data Solutions as authorised distributorPerifery appoints Titan Data Solutions as authorised distributor
advanced-television.com - February 13 at 8:31 AM
Titan Medical Inc (TMD)Titan Medical Inc (TMD)
investing.com - February 13 at 1:56 AM
Vantage Titan 3T MRI Scanner from ToshibaVantage Titan 3T MRI Scanner from Toshiba
news-medical.net - January 11 at 8:10 AM
Attack on Titan: Hajime Isayama Will Create New Titan Story in 2024Attack on Titan: Hajime Isayama Will Create New Titan Story in 2024
comicbook.com - October 3 at 1:41 AM
Five dead on Titan sub were true explorers - OceanGateFive dead on Titan sub were 'true explorers' - OceanGate
bbc.com - September 28 at 10:21 PM
TMDIF Titan Medical Inc.TMDIF Titan Medical Inc.
seekingalpha.com - August 1 at 7:27 PM
False claim Titan passenger was the vice chairman of the World Economic Forum | Fact checkFalse claim Titan passenger was the vice chairman of the World Economic Forum | Fact check
usatoday.com - July 25 at 1:09 PM
New details emerge about discovery of Titan submersible debrisNew details emerge about discovery of Titan submersible debris
en.as.com - July 19 at 9:22 AM
Destiny 2 best Titan build for PvE and PvPDestiny 2 best Titan build for PvE and PvP
videogamer.com - July 18 at 7:32 AM
Presumed human remains found in Titan sub debrisPresumed human remains found in Titan sub debris
bbc.co.uk - July 14 at 5:59 PM
The Titan submersible imploded, killing all 5 on boardThe Titan submersible imploded, killing all 5 on board
asahi.com - July 9 at 10:09 AM
Debris and Presumed Human Remains Recovered From Titan SubmersibleDebris and 'Presumed Human Remains' Recovered From Titan Submersible
msn.com - June 30 at 7:39 PM
US Coast Guard says presumed human remains found in wreckage of Titan submersibleUS Coast Guard says 'presumed human remains' found in wreckage of Titan submersible
wbaltv.com - June 30 at 1:27 PM
Titan Sub Tragedy: "Presumed Human Remains" and Mangled Debris Recovered From Atlantic OceanTitan Sub Tragedy: "Presumed Human Remains" and Mangled Debris Recovered From Atlantic Ocean
eonline.com - June 29 at 9:37 AM
Possible human remains recovered from Titan wreckage, Coast Guard saysPossible human remains recovered from Titan wreckage, Coast Guard says
msn.com - June 28 at 11:36 PM
Titan submersible tragedy could lead to lawsuits and regulatory changes, experts sayTitan submersible tragedy could lead to lawsuits and regulatory changes, experts say
yahoo.com - June 24 at 12:27 PM
What happens during a catastrophic implosion? Titan submersible occupants likely died instantlyWhat happens during a catastrophic implosion? Titan submersible occupants likely died instantly
winknews.com - June 24 at 1:01 AM
The science that put the Titan submersible at risk of implosionThe science that put the Titan submersible at risk of implosion
ktbs.com - June 24 at 1:01 AM
The Titan submersible: What could have gone wrong?The Titan submersible: What could have gone wrong?
msn.com - June 21 at 2:23 PM
Report: Banging sounds heard during Titan submersible search, according to internal memoReport: Banging sounds heard during Titan submersible search, according to internal memo
wlox.com - June 21 at 12:43 AM
Titan Medical Shares Slide as Company Pivots to IP LicensingTitan Medical Shares Slide as Company Pivots to IP Licensing
marketwatch.com - June 20 at 2:37 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Nemaura Medical logo

Nemaura Medical

NASDAQ:NMRD
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
enVVeno Medical logo

enVVeno Medical

NASDAQ:NVNO
enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.
Pro-Dex logo

Pro-Dex

NASDAQ:PDEX
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Titan Medical logo

Titan Medical

NASDAQ:TMDI
Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.